Skip to content

Testosterone findings differ for kidney disease presence and prognosis

A retrospective study found no significant hormone difference by kidney-disease status, yet reported an association with prognosis among affected men. Key details of that association remain unclear.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Testosterone levels did not differ significantly between men with and without diabetic kidney disease. Within the kidney-disease group, levels varied by disease stage, and an adjusted analysis linked testosterone to poor prognosis. These findings describe different comparisons; they do not show that testosterone causes kidney damage or that changing it improves outcomes.

Keep in mind

The abstract does not define the poor-prognosis outcome, the testosterone contrast behind the association, or the follow-up period. The prediction model also requires validation.

THE RESULT, WITH CONTEXT

What researchers found

No significant difference

Plasma testosterone concentration

Men with versus without diabetic kidney disease in the retrospective cohort; measurement timing was not reported.

BMC Endocr Disord, 2025 · Original source ↓

Several questions were examined

Researchers used existing clinical and laboratory records to examine disease presence, stage and prognosis. A prediction model combined testosterone with other patient measures, so its reported performance cannot be attributed to testosterone alone.

Interpreting the apparently different results

The absence of a significant difference between diagnostic groups does not rule out a relationship within people who already have kidney disease. However, a prognosis association still needs a clearly defined outcome and independent validation.

CHECK THE ORIGINAL

The original publication

The association of plasma testosterone level and progression of diabetic nephropathy in male.

Tang K, Du C, Zhou W et al.
BMC Endocr Disord · 2025

PubMed ID
41168769
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.